Condition
    Moderate Evidence
    Effectiveness 3/5

    Niacinamide for Acne & Breakouts

    Topical niacinamide at 4 to 5 percent reduces inflammatory acne lesions about as well as topical clindamycin, without resistance concerns. Oral niacinamide for acne is far less supported.

    Overview

    Niacinamide is one of the few acne ingredients with randomised evidence behind it that is not an antibiotic or a retinoid. A double-blinded trial comparing topical 5% nicotinamide gel with 2% clindamycin gel in mild to moderate acne found the two comparable for overall lesion reduction over eight weeks, with nicotinamide performing better in people whose skin was not oily. The practical appeal is that it does not drive resistance, does not photosensitise, and is tolerated by skin that cannot cope with benzoyl peroxide or tretinoin. It is a reasonable first topical for inflammatory papules and pustules, and a sensible partner for stronger actives rather than a replacement for them.

    Verdict

    Likely effective

    Small randomised trials of topical 4-5% niacinamide show inflammatory lesion reductions comparable to topical clindamycin over 8 weeks. Oral evidence is weaker and mostly from combination products.

    Expect a reduction in redness and inflammatory lesions rather than the clearing of comedones. Niacinamide has little effect on follicular plugging, so blackheads and closed comedones usually need a retinoid or a chemical exfoliant alongside it.

    How It Works

    Niacinamide is the amide form of vitamin B3 and a precursor to NAD+ and NADP+, the cofactors that keratinocytes rely on for energy metabolism and repair. In acne the relevant actions are anti-inflammatory rather than antimicrobial: it suppresses neutrophil chemotaxis into the follicle and dampens the interleukin-8 response that turns a plugged pore into an inflamed papule. It also improves barrier function by increasing ceramide and free fatty acid synthesis, and several small studies report reduced sebum excretion rates with sustained topical use. Because it does not kill Cutibacterium acnes, it does not select for resistant strains the way topical antibiotics do.

    Pathways involved

    Reduced neutrophil chemotaxis
    IL-8 and inflammatory cytokine suppression
    Ceramide synthesis and barrier repair
    Reduced sebum excretion rate
    NAD+ dependent keratinocyte repair
    Melanosome transfer inhibition (post-acne marks)
    The melanosome effect matters for the aftermath rather than the acne itself: by slowing pigment transfer from melanocytes to keratinocytes, niacinamide gradually fades the brown post-inflammatory marks left behind by healed lesions.

    Dosing & Protocol

    ContextDoseFormTiming
    Trial dose (topical)5% nicotinamide gel, twice dailyNicotinamide gelApplied to affected areas after cleansing
    Common cosmetic dose4-5% niacinamide serum, once or twice dailyNiacinamideLeave-on, before moisturiser
    Sensitive skin start2% niacinamide, once dailyNiacinamideBuild up over 2 weeks
    Oral (adjunct only)500 mg dailyNicotinamideWith food
    1. 1

      Patch test and start once daily· Week 1

      Apply a pea-sized amount to one area for a few days. Flushing or stinging usually means the formula concentration is too high, not that niacinamide is unsuitable.

    2. 2

      Move to twice daily on clean skin· Weeks 2-8

      Morning and night after cleansing, before moisturiser and sunscreen. The trial regimen was twice daily for eight weeks.

    3. 3

      Judge at eight weeks· Week 8

      Count inflammatory lesions at baseline and again at eight weeks. That is the window in which the randomised comparison with clindamycin showed its effect.

    4. 4

      Layer a comedolytic if needed· Ongoing

      If comedones persist while redness improves, add an adapalene or salicylic acid step at night rather than increasing niacinamide.

    Higher percentages are not better

    Formulas above 5% raise the rate of stinging and flushing without evidence of extra benefit. The randomised data sit at 4-5%.

    Oral niacinamide is sometimes used as an adjunct, usually inside combination products with zinc and copper, which makes its independent contribution hard to isolate. If you are treating acne specifically, the topical route is the one the evidence supports.

    Evidence

    The anchor study is a double-blinded randomised trial in mild to moderate acne vulgaris comparing 5% nicotinamide gel against 2% clindamycin gel. Both arms reduced acne severity over the treatment period with no significant difference overall; the nicotinamide arm did better in participants with non-oily skin, while clindamycin held a slight edge in oily skin. Supporting trials of 4% niacinamide gel report similar inflammatory lesion reductions. The literature as a whole is limited by small sample sizes, short durations and inconsistent lesion-counting methods, which is why this pairing sits at likely rather than strong.

    Studies linked to this pairing.

    Comparison of topical 5% nicotinamide gel versus 2% clindamycin gel in mild to moderate acne vulgaris: a double-blinded randomized clinical trial

    Score: 5/10
    2013
    rct
    n=80

    Khodaeiani E, Fouladi RF, Amirnia M

    Topical nicotinamide gel matched clindamycin for acne lesion reduction.

    View source
    Best available evidence
    Double-blinded RCT versus topical clindamycin, plus small supporting trials
    Typical effect
    Inflammatory lesion reduction comparable to 2% clindamycin at 8 weeks
    Studied dose
    5% nicotinamide gel twice daily
    Time to effect
    4-8 weeks
    Main limitation
    Small samples, short follow-up, few placebo-controlled arms

    Safety

    Flushing means niacin, not niacinamide

    Niacinamide does not cause the prostaglandin-mediated flush associated with nicotinic acid. Persistent stinging on application is usually the vehicle or an over-concentrated formula.

    Common effects

    Transient stinging or tingling
    Mild redness in the first week
    Dryness when layered with retinoids
    Rare contact dermatitis

    Interactions & Conflicts

    Interacts withSeverityMechanismAction
    Topical retinoids
    low
    Additive barrier disruption and irritationAlternate nights initially, or apply niacinamide in the morning
    Benzoyl peroxide
    low
    Oxidising environment can degrade some formulationsSeparate application times morning and evening
    High-dose oral nicotinamide with carbamazepine
    moderate
    Reduced carbamazepine clearance reported at gram dosesKeep oral use low and discuss with a prescriber
    The frequently repeated claim that niacinamide and vitamin C cannot be combined comes from experiments at high heat that convert niacinamide to nicotinic acid. In finished, pH-stable cosmetic formulations the two coexist without issue.

    References

    1. Shahmoradi Z et al. Comparison of topical 5% nicotinamide gel versus 2% clindamycin gel in mild to moderate acne vulgaris: a double-blinded randomized clinical trial. Int J Dermatol. 2013
    2. Walocko FM et al. The role of nicotinamide in acne treatment. Dermatol Ther. 2017

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.